FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Bert Blijenberg

Research Profile

Chemicals & Drugs

Disorders

Concepts & Ideas

Procedures

Activities & Behaviors

Quality Control

Geographic Areas

Netherlands

Co-author Network

Publications

TOP 3
Fritz H Schröder; Ulf-Hakan Stenman; Kimmo Taari; Teuvo L J Tammela; Theodorus van der Kwast; Arnauld Villers; Marco Zappa; Gunnar Aus; Anssi Auvinen; Chris H Bangma; Bert G Blijenberg; Sigrid Carlsson; Stefano Ciatto; Harry J de Koning; Louis J Denis; Matti Hakama; Andreas Huber; Jonas Hugosson; Paula M Kujala; Maciej Kwiatkowski; Hans Lilja; Marcos Lujan; Liisa Määttänen; Sue Moss; Vera Nelen; Alvaro Páez; Xavier Rebillard; Franz Recker; Monique J Roobol
Prostate-cancer mortality at 11 years of follow-up.
Chris H Bangma; Ron van Schaik; Bert G Blijenberg; Monique J Roobol; Hans Lilja; Ulf-Håkan Stenman
On the use of prostate-specific antigen for screening of prostate cancer in European Randomised Study for Screening of Prostate Cancer.
Fritz H Schröder; Jonas Hugosson; Monique J Roobol; Teuvo L J Tammela; Stefano Ciatto; Vera Nelen; Maciej Kwiatkowski; Marcos Lujan; Hans Lilja; Marco Zappa; Louis J Denis; Franz Recker; Antonio Berenguer; Liisa Määttänen; Chris H Bangma; Gunnar Aus; Arnauld Villers; Xavier Rebillard; Theodorus van der Kwast; Bert G Blijenberg; Sue Moss; Harry J de Koning; Anssi Auvinen
Screening and prostate-cancer mortality in a randomized European study.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Bert Blijenberg (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2012: Fritz H Schröder; Ulf-Hakan Stenman; Kimmo Taari; Teuvo L J Tammela; Theodorus van der Kwast; Arnauld Villers; Marco Zappa; Gunnar Aus; Anssi Auvinen; Chris H Bangma; Bert G Blijenberg; Sigrid Carlsson; Stefano Ciatto; Harry J de Koning; Louis J Denis; Matti Hakama; Andreas Huber; Jonas Hugosson; Paula M Kujala; Maciej Kwiatkowski; Hans Lilja; Marcos Lujan; Liisa Määttänen; Sue Moss; Vera Nelen; Alvaro Páez; Xavier Rebillard; Franz Recker; Monique J Roobol
Prostate-cancer mortality at 11 years of follow-up.
The New England journal of medicine 2012;366(11):981-90.
2010: Chris H Bangma; Ron van Schaik; Bert G Blijenberg; Monique J Roobol; Hans Lilja; Ulf-Håkan Stenman
On the use of prostate-specific antigen for screening of prostate cancer in European Randomised Study for Screening of Prostate Cancer.
European journal of cancer (Oxford, England : 1990) 2010;46(17):3109-19.
2009: Fritz H Schröder; Jonas Hugosson; Monique J Roobol; Teuvo L J Tammela; Stefano Ciatto; Vera Nelen; Maciej Kwiatkowski; Marcos Lujan; Hans Lilja; Marco Zappa; Louis J Denis; Franz Recker; Antonio Berenguer; Liisa Määttänen; Chris H Bangma; Gunnar Aus; Arnauld Villers; Xavier Rebillard; Theodorus van der Kwast; Bert G Blijenberg; Sue Moss; Harry J de Koning; Anssi Auvinen
Screening and prostate-cancer mortality in a randomized European study.
The New England journal of medicine 2009;360(13):1320-8.
2007: René Raaijmakers; Stijn H De Vries; Bert G Blijenberg; Mark F Wildhagen; Renske Postma; Chris H Bangma; Claude Darte; Fritz H Schröder
hK2 and free PSA, a prognostic combination in predicting minimal prostate cancer in screen-detected men within the PSA range 4-10 ng/ml.
European urology 2007;52(5):1358-64.
2007: Carsten Stephan; Chuanliang Xu; Henning Cammann; Markus Graefen; Alexander Haese; Hartwig Huland; Axel Semjonow; Eleftherios P Diamandis; Mesut Remzi; Bob Djavan; Mark F Wildhagen; Bert G Blijenberg; Patrik Finne; Ulf-Hakan Stenman; Klaus Jung; Hellmuth-Alexander Meyer
Assay-specific artificial neural networks for five different PSA assays and populations with PSA 2-10 ng/ml in 4,480 men.
World journal of urology 2007;25(1):95-103.
2005: Fritz H Schröder; Monique J Roobol; Ronald A M Damhuis; Harry J de Koning; Bert G Blijenberg; Theo Van der Kwast; Wim J Kirkels; Chris H Bangma
Rotterdam randomized pilot studies of screening for prostate cancer--an overview after 10 years.
Journal of the National Cancer Institute 2005;97(9):696.
2005: Stijn H De Vries; René Raaijmakers; Bert G Blijenberg; Stephen D Mikolajczyk; Harry G Rittenhouse; Fritz H Schröder
Additional use of [-2] precursor prostate-specific antigen and "benign" PSA at diagnosis in screen-detected prostate cancer.
Urology 2005;65(5):926-30.
2004: Stijn H De Vries; René Raaijmakers; Ries Kranse; Bert G Blijenberg; Fritz H Schröder
Prostate cancer characteristics and prostate specific antigen changes in screening detected patients initially treated with a watchful waiting policy.
The Journal of urology 2004;172(6 Pt 1):2193-6.
2004: Joop A M J L Janssen; Mark F Wildhagen; K Ito; Bert G Blijenberg; Ron van Schaik; Monique J Roobol; Huibert A P Pols; Steven W J Lamberts; F H Schröder
Circulating free insulin-like growth factor (IGF)-I, total IGF-I, and IGF binding protein-3 levels do not predict the future risk to develop prostate cancer: results of a case-control study involving 201 patients within a population-based screening with a 4-year interval.
The Journal of clinical endocrinology and metabolism 2004;89(9):4391-6.
2004: René Raaijmakers; Bert G Blijenberg; Judith A Finlay; Harry G Rittenhouse; Mark F Wildhagen; Monique J Roobol; Fritz H Schröder
Prostate cancer detection in the prostate specific antigen range of 2.0 to 3.9 ng/ml: value of percent free prostate specific antigen on tumor detection and tumor aggressiveness.
The Journal of urology 2004;171(6 Pt 1):2245-9.
2004: Chris H Bangma; Mark F Wildhagen; G Yurdakul; Fritz H Schröder; Bert G Blijenberg
The value of (-7, -5)pro-prostate-specific antigen and human kallikrein-2 as serum markers for grading prostate cancer.
BJU international 2004;93(6):720-4.
2003: Bert G Blijenberg; Hans Lilja; H Neels; Ulf-Hakan Stenman
Quality assessment for prostate-specific antigen (PSA) in relation to ERSPC: report of the PSA committee.
BJU international 2003;92 Suppl 2():66-70.
2003: Jeanne P Dieleman; Annemarie M C van Rossum; Bruno C H Stricker; Miriam C J M Sturkenboom; Ronald de Groot; Denise S C Telgt; Willem L Blok; David Burger; Bert G Blijenberg; Robert Zietse; Inge C Gyssens
Persistent leukocyturia and loss of renal function in a prospectively monitored cohort of HIV-infected patients treated with indinavir.
Journal of acquired immune deficiency syndromes (1999) 2003;32(2):135-42.
2003: Bert G Blijenberg; Mark F Wildhagen; Chris H Bangma; Judith A Finlay; Ville Väisänen; Fritz H Schröder
Comparison of two assays for human kallikrein 2.
Clinical chemistry 2003;49(2):243-7.
2003: Thomas Muley; Werner Ebert; Petra Stieber; Hannelore Raith; Stefan Holdenrieder; Dorothea Nagel; Heinrich Fürst; Heinz-Jürgen Roth; Hilmar Luthe; Bert G Blijenberg; Eberhard Gurr; Wolfgang Uhl; Joachim von Pawel; Peter Drings
Technical performance and diagnostic utility of the new Elecsys neuron-specific enolase enzyme immunoassay.
Clinical chemistry and laboratory medicine : CCLM / FESCC 2003;41(1):95-103.
2002: G Yurdakul; Chris H Bangma; Bert G Blijenberg; BD Van Zelst; Mark F Wildhagen; Theo Van der Kwast; Fritz H Schröder
Different PSA assays lead to detection of prostate cancers with identical histological features.
European urology 2002;42(2):154-8.
2001: Bert G Blijenberg; G Yurdakul; BD Van Zelst; Chris H Bangma; Mark F Wildhagen; Fritz H Schröder
Discordant performance of assays for free and total prostate-specific antigen in relation to the early detection of prostate cancer.
BJU international 2001;88(6):545-50.
1999: Bert G Blijenberg; B N Storm; BD Van Zelst; A E Kruger; Fritz H Schröder
New developments in the standardization of total prostate-specific antigen.
Clinical biochemistry 1999;32(8):627-34.
1999: Bert G Blijenberg; B N Storm; A E Kruger; F H Schröder
On the standardization of total prostate-specific antigen: an exercise with two reference preparations.
Clinical chemistry and laboratory medicine : CCLM / FESCC 1999;37(5):545-52.
1998: Bert G Blijenberg; M Roobol; Fritz H Schröder
Analytical issues on prostate-specific antigen in relation to prostate cancer screening.
Clinical biochemistry 1998;31(8):633-9.
1997: Bert G Blijenberg; M van Vliet; L Zwang
Validation of a natural urinary stone data based infrared library searching system with artificial survey samples.
European journal of clinical chemistry and clinical biochemistry : journal of the Forum of European Clinical Chemistry Societies 1997;35(8):625-30.
1997: Chris H Bangma; JB Rietbergen; Ries Kranse; Bert G Blijenberg; K Petterson; Fritz H Schröder
The free-to-total prostate specific antigen ratio improves the specificity of prostate specific antigen in screening for prostate cancer in the general population.
The Journal of urology 1997;157(6):2191-6.
1997: Chris H Bangma; Ries Kranse; Bert G Blijenberg; Fritz H Schröder
Free and total prostate-specific antigen in a screened population.
British journal of urology 1997;79(5):756-62.
1997: Bert G Blijenberg; Chris H Bangma; Ries Kranse; I Eman; F H Schröder
Analytical evaluation of the new Prostatus PSA Free/Total assay for prostate-specific antigen as part of a screening study for prostate cancer.
European journal of clinical chemistry and clinical biochemistry : journal of the Forum of European Clinical Chemistry Societies 1997;35(2):111-4.
1997: Chris H Bangma; Ries Kranse; Bert G Blijenberg; Fritz H Schröder
The free-to-total serum prostate specific antigen ratio for staging prostate carcinoma.
The Journal of urology 1997;157(2):544-7.
1996: L Zwang; Bert G Blijenberg; Henk Baadenhuijsen; B A van Landeghem; J van Pelt
The transferability of a candidate reference method for determination of creatinine in serum.
European journal of clinical chemistry and clinical biochemistry : journal of the Forum of European Clinical Chemistry Societies 1996;34(11):921-6.
1996: Bert G Blijenberg; Ries Kranse; I Eman; F H Schröder
Some analytical considerations on the measurement of prostate-specific antigen.
European journal of clinical chemistry and clinical biochemistry : journal of the Forum of European Clinical Chemistry Societies 1996;34(10):817-21.
1996: F H Shröder; R A Damhuis; Wim J Kirkels; Harry J de Koning; Ries Kranse; H G Nus; Bert G Blijenberg
European randomized study of screening for prostate cancer--the Rotterdam pilot studies.
International journal of cancer. Journal international du cancer 1996;65(2):145-51.
1995: Bert G Blijenberg; A C Kessler; W Uhl
Multicentre evaluation of a new fully automated enzyme immunoassay for total prostate-specific antigen.
European journal of clinical chemistry and clinical biochemistry : journal of the Forum of European Clinical Chemistry Societies 1995;33(12):965-73.
1995: Chris H Bangma; Ries Kranse; Bert G Blijenberg; F H Schröder
The value of screening tests in the detection of prostate cancer. Part II: Retrospective analysis of free/total prostate-specific analysis ratio, age-specific reference ranges, and PSA density.
Urology 1995;46(6):779-84.
1995: Chris H Bangma; Ries Kranse; Bert G Blijenberg; Fritz H Schröder
The value of screening tests in the detection of prostate cancer. Part I: Results of a retrospective evaluation of 1726 men.
Urology 1995;46(6):773-8.
1995: Bert G Blijenberg; R J Brouwer; Henk Baadenhuijsen; G J Boerma
Creatinine and surveys: an assessment.
European journal of clinical chemistry and clinical biochemistry : journal of the Forum of European Clinical Chemistry Societies 1995;33(11):855-8.
1995: Bert G Blijenberg; I Eman; E R Boevé; E Mössner; W Uhl
The analytical and clinical performance of the new Boehringer Mannheim Enzymun-Test PSA assay for prostate-specific antigen.
European journal of clinical chemistry and clinical biochemistry : journal of the Forum of European Clinical Chemistry Societies 1995;33(6):383-92.
1995: H Engel; D J Bac; R Brouwer; Bert G Blijenberg; Jan Lindemans
Diagnostic analysis of total protein, albumin, white cell count and differential in ascitic fluid.
European journal of clinical chemistry and clinical biochemistry : journal of the Forum of European Clinical Chemistry Societies 1995;33(4):239-42.
1995: Chris H Bangma; Bert G Blijenberg; F H Schröder
Prostate-specific antigen: its clinical use and application in screening for prostate cancer.
Scandinavian journal of clinical and laboratory investigation. Supplementum 1995;221():35-44.
1994: Bert G Blijenberg; H J Brouwer
The accuracy of creatinine methods based on the Jaffé reaction: a questionable matter.
European journal of clinical chemistry and clinical biochemistry : journal of the Forum of European Clinical Chemistry Societies 1994;32(12):909-13.
1994: H Engel; D Priem-Visser; Jan Lindemans; Bert G Blijenberg
Quantitative urinalysis with a common predilution on a DuPont Dimension.
European journal of clinical chemistry and clinical biochemistry : journal of the Forum of European Clinical Chemistry Societies 1994;32(10):805-10.
1994: Bert G Blijenberg; H J Brouwer; T J Kuller; R Leeneman; C J van Leeuwen
Improvements in creatinine methodology: a critical assessment.
European journal of clinical chemistry and clinical biochemistry : journal of the Forum of European Clinical Chemistry Societies 1994;32(7):529-37.
1994: Chris H Bangma; Bert G Blijenberg; Fritz H Schröder
[Variability of values of prostate-specific antigen determined with 6 methods].
Nederlands tijdschrift voor geneeskunde 1994;138(16):813-7.
1993: C H Schoenmakers; T Kuller; Jan Lindemans; Bert G Blijenberg
Automated enzymatic methods for creatinine measurement with special attention to bilirubin interference.
European journal of clinical chemistry and clinical biochemistry : journal of the Forum of European Clinical Chemistry Societies 1993;31(12):861-8.
1993: Bert G Blijenberg; E Giskes; J D van Suijlen
The performance of the Chem-1 revisited: an evaluation after 3 years.
European journal of clinical chemistry and clinical biochemistry : journal of the Forum of European Clinical Chemistry Societies 1993;31(11):787-91.
1993: Bert G Blijenberg; H A Roetering; H J Brouwer
Serum iron and proficiency testing: a dilemma.
European journal of clinical chemistry and clinical biochemistry : journal of the Forum of European Clinical Chemistry Societies 1993;31(4):233-7.
1993: Bert G Blijenberg; L Zwang; G J Heerenbrink
Serum creatinine and the DuPont dimension: possible improvements.
European journal of clinical chemistry and clinical biochemistry : journal of the Forum of European Clinical Chemistry Societies 1993;31(3):147-51.
1993: Bert G Blijenberg; L Zwang; M van Tilborg
New approaches with the Chem-1 creatinine determination.
European journal of clinical chemistry and clinical biochemistry : journal of the Forum of European Clinical Chemistry Societies 1993;31(1):29-33.
1992: L Zwang; Bert G Blijenberg
Validation of the ultrafiltration technique for creatinine analysis by HPLC: a comparison with direct serum injection.
European journal of clinical chemistry and clinical biochemistry : journal of the Forum of European Clinical Chemistry Societies 1992;30(12):861-6.
1992: Bert G Blijenberg; E C Liesting; L Zwang
Creatinine and automatic analysers in relation to icteric specimens.
European journal of clinical chemistry and clinical biochemistry : journal of the Forum of European Clinical Chemistry Societies 1992;30(11):779-84.
1992: Bert G Blijenberg; E C Liesting; L Zwang
On the accuracy of the Reflotron creatinine determination.
European journal of clinical chemistry and clinical biochemistry : journal of the Forum of European Clinical Chemistry Societies 1992;30(1):51-3.
1991: G Steen; Bert G Blijenberg
Chemical analysis of gallstones.
European journal of clinical chemistry and clinical biochemistry : journal of the Forum of European Clinical Chemistry Societies 1991;29(12):801-4.
1991: L Zwang; Bert G Blijenberg
Assessment of a selected method for creatinine with special emphasis on bilirubin interference.
European journal of clinical chemistry and clinical biochemistry : journal of the Forum of European Clinical Chemistry Societies 1991;29(12):795-800.
1991: J D van Suijlen; Bert G Blijenberg; G J Boerma; B Leijnse
Calibration of Technicon Chem 1 multitest analysers.
European journal of clinical chemistry and clinical biochemistry : journal of the Forum of European Clinical Chemistry Societies 1991;29(3):205-8.
1990: Bert G Blijenberg; Henk Baadenhuijsen
[Results of various analysis technics in relation to urinary calculi studies].
Nederlands tijdschrift voor geneeskunde 1990;134(29):1402-4.
1990: G Steen; Bert G Blijenberg; B Leijnse
Experiences with a new assay for pancreas specific alpha-amylase.
Annales de biologie clinique 1990;48(2):91-7.
1989: Bert G Blijenberg; G J Boerma; B Leijnse
An evaluation of the improved Technicon Chem 1 system.
Journal of clinical chemistry and clinical biochemistry. Zeitschrift für klinische Chemie und klinische Biochemie 1989;27(7):457-69.
1988: Albert W van Toorenenbergen; Bert G Blijenberg; B Leijnse
Measurement of total serum protein by near-infrared reflectance spectroscopy.
Journal of clinical chemistry and clinical biochemistry. Zeitschrift für klinische Chemie und klinische Biochemie 1988;26(4):209-11.
1987: Bert G Blijenberg; H A Roetering; A de Vos; B Leijnse
Further studies on the standardization of neonatal bilirubin.
Journal of clinical chemistry and clinical biochemistry. Zeitschrift für klinische Chemie und klinische Biochemie 1987;25(10):737-41.
1987: R W Wulkan; L Zwang; T L Liem; Bert G Blijenberg; B Leijnse
Renal stone analysis: LITHOS, an expert system for evaluation of X-ray diffractograms of urinary calculi.
Journal of clinical chemistry and clinical biochemistry. Zeitschrift für klinische Chemie und klinische Biochemie 1987;25(10):719-22.
1987: Bert G Blijenberg; H A Roetering; B Leijnse
Reflections on the standardization of total bilirubin in neonatal serum.
Journal of clinical chemistry and clinical biochemistry. Zeitschrift für klinische Chemie und klinische Biochemie 1987;25(3):177-81.
1986: Bruce Wolffenbuttel; Albert W van Toorenenbergen; Bert G Blijenberg; L Verschoor; R F A Weber
[Determination of the urinary albumin excretion in the early case-finding of nephropathy in patients with diabetes mellitus].
Nederlands tijdschrift voor geneeskunde 1986;130(44):1995-8.
1986: Bert G Blijenberg; T L Liem; B Leijnse
[Kidney stone analysis].
Nederlands tijdschrift voor geneeskunde 1986;130(8):354-6.
1985: Bert G Blijenberg; H A Roetering; L Zwang; B Leijnse
Spinal fluid protein revisited: a reappraisal of the biuret procedure.
Journal of clinical chemistry and clinical biochemistry. Zeitschrift für klinische Chemie und klinische Biochemie 1985;23(4):225-30.
1984: H A Assink; Bert G Blijenberg; G J Boerma; B Leijnse
The introduction of bromocresol purple for the determination of serum albumin on SMAC and ACA, and the standardization procedure.
Journal of clinical chemistry and clinical biochemistry. Zeitschrift für klinische Chemie und klinische Biochemie 1984;22(10):685-92.
1984: Bert G Blijenberg; H J Brouwer; H A Roetering; B Leijnse
Surveys of neonatal bilirubin. An evaluation.
Journal of clinical chemistry and clinical biochemistry. Zeitschrift für klinische Chemie und klinische Biochemie 1984;22(9):609-12.
1983: H A Assink; H J Brouwer; Bert G Blijenberg; B Leijnse
The influence of the label on the quality of a solid-phase immunoassay: evaluation of a commercial ELISA kit for serum ferritin.
Journal of clinical chemistry and clinical biochemistry. Zeitschrift für klinische Chemie und klinische Biochemie 1983;21(11):695-702.
1983: Bert G Blijenberg; B Leijnse
Application of reference methodology: determination of total protein in serum.
Journal of clinical chemistry and clinical biochemistry. Zeitschrift für klinische Chemie und klinische Biochemie 1983;21(10):601-4.
1983: C G Thomasson; Bert G Blijenberg; G A Eilers; B Leijnse
A comparative study of five different methods for the determination of 3-methoxy-4-hydroxymandelic acid in urine.
Journal of clinical chemistry and clinical biochemistry. Zeitschrift für klinische Chemie und klinische Biochemie 1983;21(7):417-27.
1982: C G Thomasson; Bert G Blijenberg; B Leijnse
Evaluation of the Technicon bound uricase method for the determination of uric acid in urine.
Journal of clinical chemistry and clinical biochemistry. Zeitschrift für klinische Chemie und klinische Biochemie 1982;20(5):299-303.
1980: A Lanser; Bert G Blijenberg; Henk C.S. Wallenburg; B Leijnse
Evaluation of an enzyme-immuno-assay for the determination of total serum estrogens in pregnancy.
Journal of clinical chemistry and clinical biochemistry. Zeitschrift für klinische Chemie und klinische Biochemie 1980;18(6):327-32.
1980: Bert G Blijenberg; B Leijnse
A survey report on the determination of total bilirubin in neonatal samples.
Journal of clinical chemistry and clinical biochemistry. Zeitschrift für klinische Chemie und klinische Biochemie 1980;18(1):27-30.